Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism*; D008297:Male; D051379:Mice; D010648:Phenylacetates / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology*; D013892:Thioxanthenes / Q000494:pharmacology*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*
D010648:Phenylacetates; D010879:Piperazines; D013892:Thioxanthenes; D014149:Tranquilizing Agents; D015102:3,4-Dihydroxyphenylacetic Acid; D006719:Homovanillic Acid